First 3D printed drug approved by US FDA now on the market
An epilepsy medication developed by Aprecia Pharmaceuticals, SPRITAM®, the first 3D printed drug approved by the US FDA, is now available on the market.
Please sign in or register for FREE
Sign in to 3DMedNet
Register to 3DMedNet
3DMedNet is a free content and networking hub aiming to encourage knowledge-sharing, interaction and discussion within the diverse 3D printing in medicine and healthcare community.